• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 5
  3. Author

Online ISSN: 2515-8260

Volume9, Issue5

TRANSFUSION OF BLOOD AND BLOOD PRODUCTS IN OBSTETRICS AT A TERTIARY CARE HOSPITAL: A PROSPECTIVE OBSERVATIONAL STUDY

    Stuti Shah, Shlok Patel, Dr. Rina Patel, Dr. Anshum Patel, Karan Jayesh Shah, Rahil Patel, Karan Hiren Shah

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 5, Pages 8-15

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Anemia and obstetric haemorrhage are major causes of maternal mortality. Both of those are the commonest indications requiring blood and component transfusion. Blood transfusion is a crucial component of comprehensive emergency obstetric care. This study was aimed to explore indications for blood and blood component transfusion in obstetrics.
Methods: This prospective observational study was carried out from January 2022 to June 2022 at a tertiary care hospital in Department of Obstetrics and Gynecology. Data was gathered from all patients who underwent transfusion of blood and/or blood products for any obstetric issue.
Results: During the study period, total 200 patients were transfused with blood and/or blood components. Two most common indications for blood transfusion were obstetric haemorrhage (64.5%) and anemia (43%). 180 patients were given PCV (90%), 80 patients received FFP (40%), 86 received PRC (43%) and 12 received cryoprecipitate (6%).
Conclusion: Maintaining a proper transfusion schedule, keeping transfusion minimum and, only using when absolutely indicated, may make blood transfusion safer and more effective. Awareness about blood donation should be increased.
 
Keywords:
    Transfusion of blood Anemia and obstetric haemorrhage blood donation Maternal mortality
  • PDF (247 K)
  • XML
(2022). TRANSFUSION OF BLOOD AND BLOOD PRODUCTS IN OBSTETRICS AT A TERTIARY CARE HOSPITAL: A PROSPECTIVE OBSERVATIONAL STUDY. European Journal of Molecular & Clinical Medicine, 9(5), 8-15.
Stuti Shah, Shlok Patel, Dr. Rina Patel, Dr. Anshum Patel, Karan Jayesh Shah, Rahil Patel, Karan Hiren Shah. "TRANSFUSION OF BLOOD AND BLOOD PRODUCTS IN OBSTETRICS AT A TERTIARY CARE HOSPITAL: A PROSPECTIVE OBSERVATIONAL STUDY". European Journal of Molecular & Clinical Medicine, 9, 5, 2022, 8-15.
(2022). 'TRANSFUSION OF BLOOD AND BLOOD PRODUCTS IN OBSTETRICS AT A TERTIARY CARE HOSPITAL: A PROSPECTIVE OBSERVATIONAL STUDY', European Journal of Molecular & Clinical Medicine, 9(5), pp. 8-15.
TRANSFUSION OF BLOOD AND BLOOD PRODUCTS IN OBSTETRICS AT A TERTIARY CARE HOSPITAL: A PROSPECTIVE OBSERVATIONAL STUDY. European Journal of Molecular & Clinical Medicine, 2022; 9(5): 8-15.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 86
  • PDF Download: 68
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus